A novel approach to target hypoxic cancer cells via combining β-oxidation inhibitor etomoxir with radiation
Hypoxia · 2018
DOI: 10.2147/hp.s163115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hypoxia, 2018. Verfasst von Arpit Dheeraj und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora,…. Die Arbeit wurde bisher 43-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
- School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.
- Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
- Department of Radiation Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
- Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA, gdeep@wakehealth.edu.
- Department of Urology, Wake Forest School of Medicine, Winston-Salem, NC, USA, gdeep@wakehealth.edu.
Förderung
- NCI NIH HHS
Zitieren
APA
Dheeraj, A., Agarwal, C., Schlaepfer, I. R., Raben, D., Singh, R., Agarwal, R., & Deep, G. (2018). A novel approach to target hypoxic cancer cells via combining β-oxidation inhibitor etomoxir with radiation. Hypoxia. https://doi.org/10.2147/hp.s163115
Vancouver
Dheeraj A, Agarwal C, Schlaepfer IR, Raben D, Singh R, Agarwal R, et al. A novel approach to target hypoxic cancer cells via combining β-oxidation inhibitor etomoxir with radiation. Hypoxia. 2018. doi:10.2147/hp.s163115
BibTeX
@article{Dheeraj2018,
author = {Dheeraj, Arpit and Agarwal, Chapla and Schlaepfer, Isabel R and Raben, David and Singh, Rana and Agarwal, Rajesh and Deep, Gagan},
title = {A novel approach to target hypoxic cancer cells via combining β-oxidation inhibitor etomoxir with radiation},
journal = {Hypoxia},
year = {2018},
doi = {10.2147/hp.s163115}
}
EUVIMED